Kidney Complications of COVID-19: A Systematic Review and Meta-Analysis

• Published in: Journal of research in health sciences Vol. 21; no. 1; p. e00503
• Main Authors: Nasiri, Naser, Rahmati, Shoboo, Etminan, Abbas, Sharifi, Hamid, Bazrafshan, Azam, Karamouzian, Mohammad, Sharifi, Ali
• Format: Journal Article
• Language: English
• Published: Iran Hamadan University of Medical Sciences 12-01-2021
• Subjects: Acute Kidney Injury - diagnosis; Acute Kidney Injury - epidemiology; Acute Kidney Injury - etiology; Acute Kidney Injury - therapy; Adult; Aged; Aged, 80 and over; COVID-19 - complications; COVID-19 - epidemiology; Cross-Sectional Studies; Female; Humans; Incidence; Male; Middle Aged; Prevalence; Review; Risk Factors; SARS-CoV-2; COVID-19; Creatinine; Blood urea nitrogen; Prevalence; Acute kidney injury
• ISSN: 2228-7795; 2228-7809
• DOI: 10.34172/jrhs.2021.39

Some patients with coronavirus disease 2019 (COVID-19) have been reported to have developed mild to severe kidney injuries. The current systematic review and meta-analysis was carried out to estimate the prevalence and incidence of acute kidney injury (AKI) among COVID-19 patients.
A systematic review and meta-analysis .
PubMed, Embase, Scopus, Web of Science, and MedRxiv databases were searched from December 1, 2019, up to July 27, 2020. Two independent co-authors completed the screening process, data extraction, and quality assessment of the retrieved records. Random-effects meta-analyses were used to determine the pooled prevalence and 95% confidence interval (CI) of AKI among COVID-19 patients.
Out of 2,332 unique identified records, 51 studies were included in the review. Overall, the studies were carried out on 25,600 patients. A total of 6,505 patients (in 18 cross-sectional studies) were included to estimate the pooled prevalence of AKI, and 18,934 patients (in 27 cohort studies) were included to determine the pooled incidence of AKI. The pooled prevalence of AKI was estimated as 10.08% (95% CI: 4.59, 17.32; I2=98.56%; P<0.001). Furthermore, the pooled incidence of AKI was 12.78% (95% CI: 7.38, 19.36; I2=99.27%; P<0.001). The mean (95% CI) values of serum creatinine (SCr), blood urea nitrogen (BUN), potassium, and sodium were 76.10 (69.36, 82.84), 4.60 (4.04, 5.30), 3.94 (3.78, 4.11), and 139.30 (138.26, 140.36) mmol/L, respectively.
The AKI is a considerable complication among COVID-19 patients and should be screened for on clinical examinations. The BUN, SCr, potassium, and sodium levels were within the normal ranges.